NL-OMON55241招募中不适用
Sickle Cell Outcome REsearch - SCORE
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •- A diagnosis of SCD of any genotype;
- •- Written patient (and in case of a patient <16 years of age, parental)
- •informed consent.
排除标准
- •- Any medical or social reason, which obstructs or inhibits study participation
- •according to treating physician
- •- Intrekking van (ouderlijke) toestemming
研究者
相似试验
招募中
不适用
Sickle Cell Outcome ResearchSickle cell diseaseNL-OMON29491A1,000
尚未招募
4 期
A study that helps in Observing patients suffering from Sickle Cell Disease, when given a treatment of crizanlizumab in Middle Eastcountries and India (SPOTLIGHT)CTRI/2022/06/043467ovartis Healthcare Pvt Ltd
招募中
3 期
Long-term Follow-up of Subjects With Sickle Cell Disease Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral Vector2024-513901-30-00Bluebird Bio Inc.3
招募中
1 期
ong-term Follow-up of Subjects With Sickle Cell Disease Treated With Ex Vivo Gene Therapy Using Autologous Hematopoietic Stem Cells Transduced With a Lentiviral VectorCTIS2024-513901-30-00Bluebird Bio Inc.88
终止
不适用
Prospective, Observational Study in Sickle Cell Disease Patients on Crizanlizumab Treatment in Middle East Countries and IndiaSickle Cell DiseaseNCT05020873Novartis Pharmaceuticals44